San Diego, CA, United States of America

Bryan Thacker

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Tega Therapeutics, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bryan Thacker. Retrieved from https://idiyas.com/inventor/bryan-thacker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Bryan Thacker

Introduction

Bryan Thacker is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of glycosaminoglycan compositions. His work focuses on the use of genetically modified cells to create these compositions, which have various applications in medicine and research.

Latest Patents

Bryan Thacker holds a patent for "Cellular glycosaminoglycan compositions and methods of making and using." This patent discloses substantially pure glycosaminoglycan compositions derived from genetically modified cells. His innovative approach has the potential to advance therapeutic methods and improve health outcomes.

Career Highlights

Thacker is currently employed at Tega Therapeutics, Inc., where he continues to explore and develop new biotechnological solutions. His expertise in glycosaminoglycans positions him as a valuable asset in the field of therapeutic development.

Collaborations

Some of his notable coworkers include Charles A. Glass and Jeffrey D. Esko. Their collaborative efforts contribute to the advancement of research and innovation within their organization.

Conclusion

Bryan Thacker's work exemplifies the impact of innovative thinking in biotechnology. His contributions to glycosaminoglycan research are paving the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…